Clinical Trials Logo

HIV clinical trials

View clinical trials related to HIV.

Filter by:

NCT ID: NCT02425241 Completed - HIV Clinical Trials

Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination

HIV-CORE003
Start date: October 2013
Phase: Phase 1/Phase 2
Study type: Interventional

This is a clinical proof-of-concept (PoC) study of DNA vaccination after SAP depletion. The investigators will measure the immune responses to DNA vaccination against HIV-1 in healthy adult male volunteers, comparing a group in whom SAP has been completely depleted at the time of DNA vaccination and a control group vaccinated without SAP depletion.

NCT ID: NCT02421406 Completed - Obesity Clinical Trials

An Internet-based Behavioral Weight Loss Program for HIV+ Patients

Start date: May 2015
Phase: N/A
Study type: Interventional

The goal of this project is to determine whether an Internet-based weight loss program will lead to weight loss and improvements in cardiovascular disease risk factors in people living with HIV.

NCT ID: NCT02419066 Completed - HIV Clinical Trials

Examining HIV Treatment Adherence During Early Disease

META
Start date: February 2015
Phase:
Study type: Observational

Determine the level, patterns, and correlates of objectively measured ART adherence in early and advanced-stage disease, among pregnant and non-pregnant individuals, to determine the need and nature of interventions to support early ART adherence in Uganda and South Africa

NCT ID: NCT02417675 Completed - HIV Clinical Trials

Postpartum Adherence Clubs to Enhance Support: the PACER Study

PACER
Start date: February 2015
Phase: N/A
Study type: Interventional

The Western Cape province of South Africa (SA) is changing the way it treats pregnant women with HIV. Now, all HIV-infected pregnant women, regardless of how sick or healthy they are, will receive antiretroviral treatment (ART) for life ("Option B+"). However, there are few well-developed models of service delivery to support this change to "Option B+" in the Western Cape and many parts of the continent. The parent study -- Strategies to Optimize ART Services for Maternal & Child Health (MCH-ART)-- is testing two clinic-based models of service delivery for Option B+ . To complement MCH-ART, this study, PACER, will test whether community-based Adherence Clubs are an effective model for keeping breastfeeding women in HIV care after pregnancy. These clubs have been used to free up space at ART clinics by moving stable HIV+ patients to community-based services, but they have not been studied as an effective strategy among breastfeeding women after delivery. PACER seeks to address this gap.

NCT ID: NCT02417233 Completed - HIV Clinical Trials

Engagement to Care South Africa

ICARE
Start date: October 2014
Phase: N/A
Study type: Interventional

This study will evaluate the efficacy of two strategies for enhancing overall preventive behaviors, retention in HIV care, and adherence to medication for HIV positive individuals in South Africa: short message service (SMS) text messaging and peer navigation services.

NCT ID: NCT02416648 Completed - HIV Clinical Trials

Effectiveness of Clinician Client Centered Counseling on Sexual Behaviors of Antiretroviral Therapy Patients in Nigeria

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the effectiveness of a clinician client centered counseling on knowledge on HIV transmission and prevention, attitudes towards HIV/AIDS, and sexual behaviors of adult HIV patients enrolled in care in Yola, Nigeria.

NCT ID: NCT02415985 Completed - HIV Clinical Trials

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Start date: June 2015
Phase: Phase 2
Study type: Interventional

To describe the pharmacokinetics of rifabutin 150 mg once daily versus rifabutin 300 mg thrice weekly in combination with LPV/r 400/100mg based HAART in HIV/TB infected patients

NCT ID: NCT02413632 Completed - HIV Clinical Trials

Screening Strategy for Asymptomatic Sexually Transmitted Infections (STI) in a Cohort of HIV Outpatients Men Who Have Sex With Men (DRIVER)

DRIVER
Start date: April 2015
Phase: N/A
Study type: Interventional

Comparison of two screening strategies of asymptomatic sexually transmitted infections : routine screening versus screening as reported by the risks taken by the patient, in a cohort of HIV outpatients men who have sex with men. The aim of this study will be create and validate a simple tool for clinicians. A digital tool will be developed will allowed empowerment of HIV-positive men who have sex with men.

NCT ID: NCT02405026 Completed - Asthma Clinical Trials

Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients

Start date: December 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine the prevalence and severity of asthma in patients with HIV. To determine the immunological phenotype of HIV-infected patients with asthma.

NCT ID: NCT02404805 Completed - HIV Clinical Trials

Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers

Start date: February 2016
Phase: N/A
Study type: Interventional

The investigator believes simeprevir concentrations are unchanged when administered in combination with dolutegravir relative to administration alone. The investigator believes dolutegravir concentrations are unchanged when administered in combination with simeprevir. Additionally, the investigator believes simeprevir and dolutegravir are safe when administered alone and in combination.